Elmeida Effendy
Departemen Psikiatri FK USU
SERT
MT1
5HT1A
NAT
5HT1B
MT2
SSRI pertama (Zimeldine) 5HT1D
5HT2C
dijual di Swedia1,3 Agomelatine disetujui di Eropa1,5,6 5HT3
5HT7
TCA pertama SNRI (Venlafaxine)
(Imipramine) dipasarkan1,2 Vortioxetine disetujui oleh FDA1,8–10
disetujui oleh FDA1,4
Vilazodone disetujui oleh FDA1,7
1. Nutt DJ. 2009; 2. Ramachandraih CT et al. 2011; 3. Faigus J et al. 1985; 4. Sansone RA et al. 2014; 5.
Fornaro M et al.2022 WEBINAR
2010; 6. Agomelatine EPAR; 7. Cruz MP. 2012; 8.KESEHATAN NASIONAL-TERAPI
Bang-Andersen DEPRESI
B et al. 2011; 9. DARI
Westrich L SUDUT
25 September 10
et al. 2012; 10. Vortioxetine Prescribing Information. PANDANG DOKTER DAN APOTEKER
Classic antidepressants :
Monoamine oxidase inhibitors (MAOIs)
Antidepresan pertama yang ditemukan efektif secara klinik, Ketika
mengobservasi anti tuberculosis untuk mengobati depresi
Monoamine oxidase inhibitor (MAOIs)bekerja dengan cara
menghambat kinerja senyawa noradrenalin dan serotonin untuk
mencegah timbulnya gejala depresi.
• Contoh obat golongan MAOIs adalah:
• Phenelzine
• Tranylcypromine
• Isocarboxazid
• Venlafaxine
• Desvenlafaxine
• Duloxetine
• Milnacipran
Agomelatine1,2 Vortioxetine1,3,4
Multimodal?
3 pharmacological targets
MT1 but 1 mode of action SERT 5HT1A
(receptor activity)
5HT1B
MT2 Multimodal?
6 pharmacological 5HT1D
5HT2C targets and
2 modes of action 5HT3
(receptor activity +
reuptake inhibition) 5HT7
WEBINAR KESEHATAN NASIONAL-TERAPI DEPRESI DARI SUDUT
25 September 2022 20
PANDANG DOKTER DAN APOTEKER
Hubungan Modulasi Reseptor Serotonin dengan
Efek Antidepresan dan Prokognitif
Antidepresan dan
Reseptor Manfaat Farmakologi Manfaat/Tolerabilitas
Prokognitif 1-7
Antidepresan, kognisi, Menormalkan libido/keterjagaan 8
5-HT1A Agonis rilis 5-HT
anksiolitik
Parsial agonis level 5-HT
5-HT1B Antidepresan BB 9
ekstraseluler
1. American Psychiatric Association A. Practice guideline for the treatment of patients with major depressive disorder. 3 rd ed. Arlington, VA: American Psychiatric Association; 2010;
2. Taylor et al. Maudsley Prescribing Guidelines, 10th Edition, 2009;
3. European Medicines Agency (EMA). Summary of Product Characteristics for Valdoxan (agomelatine). 2009. Updated July 16, 2014. Accessed October 27, 2014;
4. Forest Laboratories Inc. Prescribing Information for Viibryd (vilazodone hydrochloride). 2012. Updated April 2014.
Efek Samping Antidepresan
Nervousness
Constipation
Somnolence
Weight gain
dysfunction
Male sexual
Dry mouth
Headache
Diarrhoea
Increased
Dizziness
Sweating
Insomnia
Agitation
Anorexia
Asthenia
appetite
Nausea
Anxiety
Fatigue
Tremor
Class Drug
• Citalopram
• Escitalopram
• Fluoxetine
SSRI • Fluvoxamine
0–9%
• Paroxetine
• Sertraline 10–29%
• Desvenlafaxine
• Duloxetine 30%
SNRI • Levomilnacipran
• Milnacipran
• Venlafaxine * Based on
• Agomelatine unadjusted rates
• Bupropion from product
• Mirtazapine monographs
Other
• Moclobemide
• Vilazodone
• Vortioxetine
Adapted from: Kennedy et al. Can J Psychiatry. 2016 Sep;61(9):540-60.
Memilih Antidepresan
• Berdasarkan gejala
• Berdasarkan efek samping
• Berdasarkan cost benefit ratio
• Share decision making